A list of recently published and updated articles regarding medical device regulatory updates from the governing bodies throughout Asia.

India Extends Deadline for Class C and D Import Licenses

On May 16th, 2024 India’s CDSCO extended allowances for the importation of Class C and D Medical Devices currently under review.

Indonesia Invests in Quality Healthcare Access

On May 6th, 2024 the President of Indonesia, Joko Widodo launched the new hospital-based Specialist Doctor Education Program which supports Indonesia’s growing commitment to the healthcare industry and provides strong support for investment in Indonesia. 

Indonesia Implements GDPMD Requirement

On April 30th, 2024, the Ministry of Health in Indonesia announced that it will be implementing a Good Distribution Practice of Medical Devices (GDPMD) requirement.

Indonesia Boosts Medical Device Sales Prospects

Recent developments have made the Indonesian market an even more attractive place to generate medical device sales growth.

Asia Actual Summit in Indonesia

April 23rd to 27th, 2024, Asia Actual Indonesia hosts Asia Actual USA, Singapore, China, Vietnam, Philippines, and Thailand, for a Summit.

Medical Device Risk Classification Problems in Vietnam

According to a report published on May 7th, 2024, contractors have been apprehended misrepresenting IVD and Medical Device risk classification to participate in bidding parties.

Philippines Issues Guidance on Medical Device Labeling

On April 5th, the CDRRHR provided guidance for CMDR medical device labeling in the Philippines related to previously CMDN labeled stock.

Innovative Medical Device Registration in Japan

In 2019, Japan’s Ministry of Health, Labor and Welfare (MHLW) and Pharmaceuticals and Medical Devices Agency (PMDA) introduced a innovative device registration designation system, called Sakigake, which is meant to streamline the regulatory pathway for qualifying medical products.

Medical Device Consultation in Japan

Medical device consultation in Japan is a very involved but essential process in registering a medical device. A significant part of the regulatory process in Japan is consultation meetings with the Pharmaceuticals and Medical Devices Agency (PMDA).

Australia’s SaMD Regulatory Deadline

Beginning on November 1st, 2024, Australia’s Therapeutic Goods Administration will implement new rules surrounding software as a medical device (SaMD). While some SaMD will require additional regulatory requirements, other SaMD will be exempted from some, or excluded completely, from the new regulations.